Who’s Most at Risk—and Why It Might Be You

For the past two weeks, we’ve been building a picture of what GLP-1 medications actually do beyond appetite suppression—specifically, how they dampen dopamine signaling and what that means for motivation, drive, and your sense of self.

Today I want to get personal. Because these effects don’t hit everyone equally.

Some People Are Already Running Low

Dopamine isn’t a fixed resource. It fluctuates based on your biology, your life circumstances, your hormonal status, your stress load, and how long you’ve been pushing through without adequate support.

And some people walk into a GLP-1 prescription already running on fumes.

If You’re in Perimenopause or Postmenopause

Estrogen directly supports dopamine production and receptor sensitivity. As estrogen declines—and it doesn’t decline gracefully; it swings and plummets—dopamine signaling takes a hit. That’s a big part of why midlife women describe losing their edge, their spark, their ability to care the way they used to.

Now add a medication that further suppresses reward signaling. You’re not starting from a full tank. You’re starting from a quarter tank and draining it faster.

If You’re a Chronic Dieter

Years of restriction and deprivation have already trained your brain to downregulate reward. Your dopamine system has been through cycles of feast-and-famine signaling, and it’s adapted by becoming less responsive overall. You may already know the feeling of food not being satisfying even when you eat it—that’s not willpower. That’s a worn-out reward system.

Adding pharmacological suppression on top of a system that’s already exhausted isn’t support. It’s depletion.

If You Carry Trauma

Trauma dysregulates the nervous system, and the nervous system and dopamine pathways are deeply intertwined. Chronic hypervigilance burns through neurochemical resources. Many trauma survivors already live in a state of emotional flattening as a protective mechanism—their system learned to mute feelings to survive.

A medication that further mutes reward and pleasure can push someone from “managing” into truly numb territory. And numb is not the same as healed.

If You Have an ADHD-Type Brain

ADHD is, at its core, a dopamine regulation issue. These brains already struggle with motivation, follow-through, and the ability to find sustained reward in everyday tasks. GLP-1 medications can amplify every one of those struggles while simultaneously removing one of the most reliable dopamine sources many ADHD brains rely on: food.

If You’re a Burned-Out Caregiver

Caregiving—whether for children, aging parents, clients, or all of the above—is a chronic dopamine drain. You’re giving, giving, giving with diminishing returns to your own reward system. The exhaustion isn’t just physical. It’s neurochemical.

These are the women who come to me saying, “I just want to feel like myself again.” And my honest concern is that a GLP-1 might take them further from that, not closer.

If You Live in the Modern World (Which Is All of Us)

I mentioned this briefly last week, but it deserves its own space here—because this isn’t just another risk factor. It’s the water we’re all swimming in.

We live in an environment that was designed—deliberately, by very smart engineers—to hijack dopamine. Social media algorithms, push notifications, autoplay content, likes, comments, streaks, infinite scroll. Every one of those features exists because it triggers a small dopamine release that keeps you coming back. That’s not a conspiracy theory. It’s the business model.

And it’s not just phones. It’s same-day delivery. It’s on-demand everything. It’s a world where waiting has been nearly eliminated, and with it, our tolerance for the slow, earned satisfaction that healthy dopamine signaling is built on.

The result? Most of us are living with dopamine systems that are simultaneously overstimulated and undernourished. We’re getting constant micro-hits but very few deep, sustained rewards. And over time, the brain adapts by becoming less responsive to all of it—including the quiet, real-life pleasures that used to be enough.

Now layer a GLP-1 medication on top of that.

You’re not just suppressing reward signaling in a healthy brain. You’re suppressing it in a brain that’s already been trained to need more stimulation to feel anything at all. The modern dopamine environment doesn’t just make GLP-1 side effects more likely—it makes them harder to recognize, because so many people have already normalized feeling numb, distracted, and unable to enjoy ordinary life.

This is the invisible risk factor. It doesn’t show up on any screening questionnaire. But it’s affecting virtually everyone who fills that prescription.

The Common Thread

Every one of these groups has the same underlying vulnerability: a dopamine system that’s already compromised. They’re not starting from baseline. They’re starting from a deficit. And when you suppress a system that’s already struggling, you don’t get fine-tuning. You get shutdown.

This isn’t about fear. It’s about informed consent. If you’re in one of these categories and you’re considering a GLP-1—or you’re already on one and something feels off—that feeling is data. Don’t dismiss it.

	Coming next week: What actually happens when people stop GLP-1 medications—the rebound cravings, the emotional crash, and why the weight often returns. It’s not a willpower failure. It’s a system that was suppressed, not restored.
Disclaimer: This post is for informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or qualified health care provider before making changes to any treatment plan. Do not stop or modify GLP-1 or any other medication without guidance from your prescribing provider.